Injectable Contraceptive Use and Genital Ulcer Disease during the Early Phase of HIV-1 Infection Increase Plasma Virus Load in Women

Journal of Infectious Diseases

Volumn 189, Issue 2, 2004, Pages 303-311

  Lavreys, Ludo ^a   Baeten, Jared M ^a   Kreiss, Joan K ^a   Richardson, Barbra A ^a,b   Chohan, Bhavna H ^c   Hassan, Wisal ^c   Panteleeff, Dana D ^b   Mandaliya, Kishorchandra ^d   Ndinya Achola, Jeckoniah O ^c   Overbaugh, Julie ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Center and University of Washington   (United States)

^c UNIVERSITY OF NAIROBI   (Kenya)

^d Department of Oral and Maxillofacial Surgery   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; MEDROXYPROGESTERONE ACETATE; VIRUS RNA;

ADULT; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CONTRACEPTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; FEMALE; FOLLOW UP; GENITAL ULCER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SERODIAGNOSIS; SEXUAL BEHAVIOR; VIREMIA; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; COHORT STUDIES; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; GENITAL DISEASES, FEMALE; HIV-1; HUMANS; INJECTIONS; MEDROXYPROGESTERONE 17-ACETATE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; RNA, VIRAL; SEXUAL BEHAVIOR; ULCER; VIRAL LOAD;

EID: 9144259112     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/380974     Document Type: Article

References (51)

1. Kahn J, Walker B. Acute human immunodeficiency type 1 infection. N Engl J Med 1998; 339:33-9.
2. Little SJ, McLean AR, Spina CA, Richman DD, Havlir DV. Viral dynamics of acute HIV-1 infection. J Exp Med 1999; 190:841-50.
3. Kaufmann G, Cunningham P, Kelleher A, et al. Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection. J Infect Dis 1998; 178:1812-5.
4. Schacker TW, Hughes JP, Shea T, Coombs RW, Corey L. Biological and virologic characteristics of primary HIV infection. Ann Intern Med 1998; 128:613-20.
5. Ho D. Viral counts count in HIV infection. Science 1996; 272:1124-5.
6. Henrard D, Phillips J, Muenz L, et al. Natural history of HIV-1 cell-free viremia. JAMA 1995; 274:554-8.
7. Mellors J, Kingsley L, Rinaldo C, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995; 122:573-9.
8. Mellors J, Rinaldo C, Phalguni G, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272:1167-70.
9. + lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996; 334:426-31.
10. Kimata J, Kuller L, Anderson D, Dailey P, Overbaugh J. Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression. Nat Med 1999; 5:535-41.
11. de Roda Husman A, Koot M, Cornelissen M, et al. Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann Intern Med 1997; 127:882-90.
12. John G, Bird T, Overbaugh J, et al. CCR5 promotor polymorphisms in a Kenyan perinatal human immunodeficiency virus type 1 cohort: association with increased 2-year maternal mortality. J Infect Dis 2001; 184:89-92.
13. Phair J, Jacobson L, Detels R, et al. Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1992; 5:490-6.
14. Marx P, Spira A, Gettie A, et al. Progesterone implants enhance SIV vaginal transmission and early viral load. Nature Med 1996; 2:1084-9.
15. Schnittman S, Greenhouse J, Lane H, Pierce P, Fauci A. Frequent detection of HIV-1-specific mRNAs in infected individuals suggests ongoing active viral expression in all stages of disease. AIDS Res Hum Retroviruses 1991; 7:361-7.
16. Holodniy M, Katzenstein D, Sengupta S, et al. Detection and quantification of human immunodeficiency virus RNA in patient serum by use of the polymerase chain reaction. J Infect Dis 1991; 163:862-6.
17. Lyles R, Munoz A, Yamashita T, et al. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. J Infect Dis 2000; 181: 872-80.
18. Farzadegan H, Henrard D, Kleeberger C. Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13:448-55.
19. + cell count. JAMA 1998; 279:35-40.
20. O'Brien T, Blattner W, Waters D, et al. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA 1996; 276:105-10.
21. Anastos K, Kalish L, Hessol N, et al. The relative value of CD4 cell count and quantitative HIV-1 RNA in predicting survival in HIV-1-infected women: results of the women's interagency HIV study. AIDS 1999; 13:1717-26.
22. Morgan D, Rutebemberwa A, Malamba S, et al. HIV-1 RNA levels in an African population-based cohort and their relation to CD4 lymphocyte counts and World Health Organization clinical staging. J Acquir Immune Defic Syndr 1999; 22:167-73.
23. + T-cell counts among HIV-infected Africans evaluated for antiretroviral therapy. J Acquir Immune Defic Syndr 2001; 28:99-101.
24. Napravnik S, Poole C, Thomas J, Eron J. Gender difference in HIV RNA levels: a meta-analysis of published studies. J Acquir Immune Defic Syndr 2002; 31:11-9.
25. Martin H, Nyange P, Richardson B, et al. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis 1998; 178:1053-9.
26. Nugent R, Krohn M, Hillier S. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991; 29:297-301.
27. Holmes K, Stamm W. Lower genital tract infection syndromes in women. In: Holmes K, Mardh P, Sparling P, eds. Sexually transmitted diseases. 3rd ed. New York: McGraw-Hill, 1999:761-81.
28. Emery S, Bodrug S, Richardson B, et al. Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya. J Clin Microbiol 2000; 38:2688-95.
29. Lavreys L, Baeten JM, Overbaugh J, et al. Virus load during primary human immunodeficiency virus (HIV) type 1 infection is related to the severity of acute HIV illness in Kenyan women. Clin Infect Dis 2002; 35:77-81.
30. Busch M, Lee L, Satten G, et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995; 35:91-7.
31. Pardthaisong T, Gray RH, McDaniel EB. Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine devices in Northern Thailand. Lancet 1980; 1:509-12.
32. Bracken MB, Hellenbrand KG, Holford TR. Conception delay after oral contraceptive use: the effect of estrogen dose. Fertil Steril 1990; 53:21-7.
33. Baeten JM, Nyange PM, Richardson BA, et al. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol 2001; 185:380-5.
34. Mehendale SM, Bollinger RC, Kulkarni SS, et al. Rapid disease progression in human immunodeficiency virus type 1-infected seroconverters in India. AIDS Res Hum Retroviruses 2002; 18:1175-9.
35. Andersson S, Norrgren H, da Silva Z, et al. Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma viral set point in HIV-2 than in HIV-1 infection. Arch Intern Med 2000; 160:3286-93.
36. Salamon R, Marimoutou C, Ekra D, et al. Clinical and biological evolution of HIV-1 seroconverters in Abidjan, Cote d'Ivoire, 1997-2000. J Acquir Immune Defic Syndr 2002; 29:149-57.
37. Anzala O, Nagelkerke N, Bwayo J, et al. Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J Infect Dis 1995; 171:686-9.
38. Kiddugavu M, Makumbi F, Wawer M, et al. Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda. AIDS 2003; 17:233-40.
39. + T cells in the cervical epithelium of healthy women. J Reprod Immunol 2002; 54:117-31.
40. Patterson B, Landay A, Andersson J, et al. Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. Am J Pathol 1998; 153:481-90.
41. Hunt J, Miller L, Platt J. Hormonal regulation of uterine macrophages. Dev Immunol 1998; 6:105-10.
42. Sagar M, Lavreys, Baeten JM, et al. Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population. AIDS (in press).
43. Kaushic C, Ashkar A, Reid L, Rosenthal K. Progesterone increases susceptibility and decreases immune responses to genital herpes infection. J Virol 2003; 77:4558-65.
44. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002; 185:45-52.
45. del Mar Pujades Rodriguez M, Obasi A, Mosha F, et al. Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania. AIDS 2002; 16:451-62.
46. Schacker T, Collier A, Hughes J, Shea T, Corey L. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 1996; 125:257-64.
47. Mostad SB, Kreiss JK, Ryncarz AJ, et al. Cervical shedding of herpes simplex virus in human immunodeficiency virus-infected women: effects of hormonal contraception, pregnancy, and vitamin A deficiency. J Infect Dis 2000; 181:58-63.
48. Schacker T, Zeh J, Hu H, Shaughnessy M, Corey L. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis 2002; 186:1718-25.
49. Moriuchi M, Moriuchi H, Williams R, Straus SE. Herpes simplex virus infection induces replication of human immunodeficiency virus type 1. Virology 2000; 278:534-40.
50. Moriuchi M, Moriuchi H. In vitro reactivation of HIV-1 by stimulation with herpes simplex virus infection. Sex Transm Dis 2002; 29:308-9.
51. Mole L, Ripich S, Margolis D, Hologniy M. The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 1997; 176:766-70.